These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7634621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J, Kruszewski WJ, Sliwińska M, Kruszewska E, Hajdukiewicz W, Sliwiński W, Rolka-Stempniewicz G, Góralczyk M, Leśniewski-Kmak K.
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN.
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [Abstract] [Full Text] [Related]

  • 5. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
    Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y, Qu X.
    J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors determining survival in breast cancer patients presenting with metastatic disease.
    Jubelirer SJ, Wilson R, Summers L, Richardson S.
    W V Med J; 1990 Jan; 86(1):7-9. PubMed ID: 2301163
    [Abstract] [Full Text] [Related]

  • 7. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M, García González JI, Mora Durvan M, Díez Rodríguez JM, Esteban Artiaga R, Navarro Sebastián J, Castro Pita M, Paniagua Andrés P.
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A, Wanek LA, Morton DL.
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.
    Grøndahl-Hansen J, Christensen IJ, Briand P, Pappot H, Mouridsen HT, Blichert-Toft M, Danø K, Brünner N.
    Clin Cancer Res; 1997 Feb; 3(2):233-9. PubMed ID: 9815678
    [Abstract] [Full Text] [Related]

  • 11. [Bone metastasis in breast carcinoma].
    Kölbl O, Kiricuta IC, Willner J, Flentje M.
    Zentralbl Chir; 1997 Feb; 122(2):97-102. PubMed ID: 9173765
    [Abstract] [Full Text] [Related]

  • 12. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M.
    Acta Oncol; 2008 Feb; 47(2):232-8. PubMed ID: 17924207
    [Abstract] [Full Text] [Related]

  • 13. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.
    Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
    [Abstract] [Full Text] [Related]

  • 14. Surgical treatment of bone metastases in patients with breast cancer.
    Dürr HR, Müller PE, Lenz T, Baur A, Jansson V, Refior HJ.
    Clin Orthop Relat Res; 2002 Mar; (396):191-6. PubMed ID: 11859243
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
    Kuru B, Camlibel M, Dinc S, Gulcelik MA, Gonullu D, Alagol H.
    Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
    [Abstract] [Full Text] [Related]

  • 16. [Natural history and development of bone metastasis. Apropos of 429 cases].
    Conroy T, Malissard L, Dartois D, Luporsi E, Stines J, Chardot C.
    Bull Cancer; 1988 Nov; 75(9):845-57. PubMed ID: 3207894
    [Abstract] [Full Text] [Related]

  • 17. The influence of basal phenotype on the metastatic pattern of breast cancer.
    Luck AA, Evans AJ, Green AR, Rakha EA, Paish C, Ellis IO.
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444
    [Abstract] [Full Text] [Related]

  • 18. [Clinical results and prognostic factors of radiotherapy for bone metastases from breast cancer].
    Yoden E, Murakami M, Kuroda Y, Kono K, Sasaki R.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jan; 59(1):27-33. PubMed ID: 10067313
    [Abstract] [Full Text] [Related]

  • 19. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C, Cuppone F, Bria E, Fornier M, Giannarelli D, Mottolese M, Novelli F, Natoli G, Cognetti F, Terzoli E.
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and surgical treatment of metastatic lung tumors].
    Yamamoto Y, Hirata T, Fukuse T, Yokomise H, Ike O, Mizuno H, Wada H, Hitomi S, Nakamura T, Shimizu Y.
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.